Israel - inglês - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 0.1 %w/w - cream - dithranol - topical treatment of sub-acute & chronic psoriasis,including psoriasis of the scalp.

Israel - inglês - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 0.25 %w/w - cream - dithranol - topical treatment of sub-acute & chronic psoriasis,including psoriasis of the scalp.

Israel - inglês - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 1 %w/w - cream - dithranol - topical treatment of sub-acute & chronic psoriasis,including psoriasis of the sculp.

Israel - inglês - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 0.5 %w/w - cream - dithranol - topical treatment of sub-acute & chronic psoriasis,including psoriasis of the scalp.

Israel - inglês - Ministry of Health

trupharm marketing 1985 ltd. - dithranol 2 %w/w - cream - dithranol - topical treatment of subacute and chronic psoriasis including psoriasis of the scalp.

Israel - inglês - Ministry of Health

trupharm marketing 1985 ltd. - benzalkonium chloride 0.5 %w/v; isopropyl myristate 25 %w/v - emulsion - benzalkonium - for the treatment of dry skin conditions especially associated with eczema, ichtyosis or xeroderma. it permits rehydratation of the keratin.

Estados Unidos - inglês - NLM (National Library of Medicine)

trupharma llc. - primidone (unii: 13afd7670q) (primidone - unii:13afd7670q) - primidone, used alone or concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. it may control grand mal seizures refractory to other anticonvulsant therapy. primidone is contraindicated in: 1) patients with porphyria and 2) patients who are hypersensitive to phenobarbital (see actions ).

Estados Unidos - inglês - NLM (National Library of Medicine)

trupharma, llc - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 25 mg - venlafaxine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of venlafaxine tablets, usp in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii or dsm-iii-r category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the efficacy of ve

Estados Unidos - inglês - NLM (National Library of Medicine)

trupharma, llc - paroxetine hydrochloride anhydrous (unii: 3i3t11ud2s) (paroxetine - unii:41vrh5220h) - paroxetine 10 mg - major depressive disorder: paroxetine tablets are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets in hospitalized depressed patients have not been adequately studied.

Estados Unidos - inglês - NLM (National Library of Medicine)

trupharma, llc - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride oral solution is indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions ( 5.2)] , reserve tramadol hydrochloride oral solution for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: - have not been tolerated or are not expected to be tolerated. - have not provided adequate analgesia or are not expected to provide adequate analgesia. tramadol hydrochloride oral solution is contraindicated for: - all children younger than 12 years of age [see warnings and precautions ( 5.5)] . - postoperative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see warnings and pre